Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 



